---
title: "US Stock Movement | Reports indicate negotiations for acquisition with at least one large pharmaceutical company, Moderna rises over 9%"
description: "On Thursday, Moderna's stock price rose, and as of the time of writing, the stock was up over 9%, trading at $26.95. On the news front, a person familiar with the discussions revealed that the company"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263571808.md"
published_at: "2025-10-30T15:50:04.000Z"
---

# US Stock Movement | Reports indicate negotiations for acquisition with at least one large pharmaceutical company, Moderna rises over 9%

> On Thursday, Moderna's stock price rose, and as of the time of writing, the stock was up over 9%, trading at $26.95. On the news front, a person familiar with the discussions revealed that the company is in acquisition negotiations with at least one large pharmaceutical company for a large-scale deal

According to Zhitong Finance APP, on Thursday, Moderna (MRNA.US) shares rose, with the stock up over 9% as of the time of writing, priced at $26.95. On the news front, a person familiar with the discussions revealed that the company has been in acquisition negotiations for a large-scale deal with at least one major pharmaceutical company

### Related Stocks

- [MRNA.US - Moderna](https://longbridge.com/en/quote/MRNA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Moderna Signs Five-Year Supply and Manufacturing Agreement with Mexican Government | Moderna Inc. has signed a five-year agreement with the Mexican Government and local partners for the supply of its respi | [Link](https://longbridge.com/en/news/275453337.md) |
| Mexico enlists Moderna to boost mRNA supply for respiratory diseases | Mexico has entered a long-term agreement with Moderna to enhance its mRNA vaccine supply for respiratory diseases as par | [Link](https://longbridge.com/en/news/275641500.md) |
| Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X | Defiance ETFs has launched a new 2X leveraged ETF linked to Moderna Inc (NASDAQ:MRNA), named the Defiance Daily Target 2 | [Link](https://longbridge.com/en/news/275363047.md) |
| Moderna Q4 revenue beats estimates on COVID vaccine sales, influenza vaccine filing accepted | Moderna's Q4 revenue reached $0.7 billion, surpassing analyst expectations, driven mainly by COVID vaccine sales. The co | [Link](https://longbridge.com/en/news/275897109.md) |
| Polymarket Odds: Will MRNA and WEN Beat Earnings Tomorrow? | On February 13, Moderna (MRNA) and Wendy's (WEN) will report earnings. Moderna is expected to report a GAAP EPS loss of  | [Link](https://longbridge.com/en/news/275798964.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.